Löfberg M, Jänkälä H, Paetau A, Härkönen M, Somer H
Institute of Neurosciences, Department of Neurology, Helsinki University Central Hospital, Finland.
Acta Neurol Scand. 1998 Oct;98(4):268-75. doi: 10.1111/j.1600-0404.1998.tb07307.x.
The aim of the study was to evaluate the biochemical causes of recurrent rhabdomyolysis in Finland.
We examined 22 patients with recurrent rhabdomyolysis, and 26 patients with one episode of rhabdomyolysis or other symptoms compatible with metabolic myopathy. Muscle histopathology and activities of phosphorylase (PHRL) (total and active), phosphofructokinase (PFK), carnitine palmitoyltransferase (CPT) and myoadenylate deaminase (MAD) were studied. The limit of enzyme deficiency was defined as enzyme activity less than 5% of the mean of the control subjects.
We found 4 patients with muscle PHRL deficiency, 1 patient with PFK deficiency and 1 patient with evidence of phosphorylase kinase deficiency. One patient had Becker's muscle dystrophy, 2 patients had unspecified dystrophies, 1 patient had Miyoshi myopathy, and 1 patient had a form of mitochondrial encephalomyopathy (MELAS).
Enzyme defects were found in 23% of the patients with recurrent rhabdomyolysis. Other muscle diseases, muscular dystrophies or myopathies, were detected in 18% of these patients, emphasizing the value of clinical and histopathological examination of patients with previous rhabdomyolysis.
本研究旨在评估芬兰复发性横纹肌溶解症的生化病因。
我们检查了22例复发性横纹肌溶解症患者,以及26例有过一次横纹肌溶解发作或有其他与代谢性肌病相符症状的患者。研究了肌肉组织病理学以及磷酸化酶(PHRL)(总活性和活性)、磷酸果糖激酶(PFK)、肉碱棕榈酰转移酶(CPT)和肌腺苷酸脱氨酶(MAD)的活性。酶缺乏的界限定义为酶活性低于对照受试者平均值的5%。
我们发现4例患者存在肌肉PHRL缺乏,1例患者存在PFK缺乏,1例患者有磷酸化酶激酶缺乏的证据。1例患者患有贝克尔型肌营养不良症,2例患者患有未明确的肌营养不良症,1例患者患有三宅氏肌病,1例患者患有某种形式的线粒体脑肌病(MELAS)。
在复发性横纹肌溶解症患者中,23%发现有酶缺陷。在这些患者中,18%检测出其他肌肉疾病、肌营养不良症或肌病,这强调了对既往有横纹肌溶解症患者进行临床和组织病理学检查的价值。